Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi Releases Annual Drug Price Report Ahead Of Senate Hearing

Executive Summary

Sanofi's annual report on its drug price increases echoed a theme heard during recent 2018 earnings calls, with list price hikes offset by rebates resulting in a net price decline.

Advertisement

Related Content

Big Pharma CEOs Get Ready To Testify: Preparing For A No-Win Situation
Invitation Accepted: Biopharma Leaders Will Testify At Senate Hearing On Pricing
Sanofi/Regeneron's IO Springboard Libtayo Cleared For Skin Cancer
Who's Promised What: A Guide To Pharma Drug Pricing Pledges
Lowering Insulin Costs: Sanofi Seeks HHS Support For Expanding Assistance To Medicare Patients
Sanofi's Drug Pricing Pledge Ties Increases To National Health Expenditure

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC124708

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel